However, as second‐trimester maternal serum screening for fetal aneuploidy has been replaced by first‐trimester screening in many parts of the world, the rarity of HCC in pregnancy does not justify maintaining AFP assessment for the sole purpose of HCC detection. This evidence concerns the gene AFP and hepatocellular carcinoma.